2HDC02

TIME: 13:30 - 17:00
TITLE OF THE COURSE: MULTIPLE SCLEROSIS II
CREDIT: 2 CREDITS
1- COURSE IS RECOMMENDED FOR: RESIDENT, SPECIALIST NEUROLOGIST, ACADEMICIAN
2- COURSE OBJECTIVE:
In this course, injectable therapies, oral therapies, monoclonal antibodies and changing treatment algorithms in MS and treatment changing criteria will be reviewed. Symptomatic therapies and treatment of NMO / NMO spectrum diseases in MS will also be handled.
3- THE SUBJECTS THAT THE COURSE ATTENDEES WILL BE INFORMED AFTER THE COURSE
Attendees of this course will be informed about and experienced in injectable therapies, oral therapies, monoclonal antibody therapies in MS, changing treatment algorithms in MS and treatment switching practices. In addition, approaches to symptomati treatment management and treatment of NMO / NMO spectrum diseases in MS will be presented
4- EXPECTATIONS FROM THE ATTENDEES: ATTENDING AS A LISTENER, SHARING EXPERIENCES, PARTICIPATING IN THE APPLICATIONS, ACTIVE PARTICIPATION IN DISCUSSIONS
5- COURSE PROGRAM

Title of the session:
Current Developments in MS /NMO Treatment, Current Overview of Treatment Algorithms

Chairs of the Session:
Hüsnü Efendi (Kocaeli University Faculty of Medicine, Dept. of Neurology)
Cavit Boz (Karadeniz Technical University Faculty of Medicine, Dept. Of Neurology)

Speakers and Topics:
• Treatment approach in NMO and NMO spectrum diseases
Ayşe Altıntaş (Koç University Faculty of Medicine, Dept. of Neurology)
• The role of injectable immunomodulatory treatments in the treatment of MS
Taşkın Duman (Mustafa Kemal University Faculty of Medicine, Dept. of Neurology)
• Oral treatments; Place in the treatment of MS
Yeşim Beckmann (İzmir Katip Çelebi University Atatürk Training and Research Hospital, Neurology Clinic)
• Discussion and Comments by the Chairs of the Session

15:00 - 15:30 Coffee Break

Speakers and Topics:
• Monoclonal antibodies; their place in the treatment of MS
Şeref Demirkaya (Gülhane Training and Research Hospital, Neurology Clinic)
• Treatment change in multiple sclerosis; What to do, for which patient?
Ömer Faruk Turan (Uludağ University Faculty of Medicine, Dept. of Neurology)
• Symptomatic treatment management in multiple sclerosis
Sibel Canbaz Kabay (Kütahya Health Sciences University Faculty of Medicine, Dept. Of Neurology)
• Discussion and Comments by the Chairs of the Session